Ferroptosis-Regulated Cell Death as a Therapeutic Strategy for Neurodegenerative Diseases: Current Status and Future Prospects
- 14 August 2023
- journal article
- review article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 14 (17) , 2995-3012
Abstract
Ferroptosis is increasingly being recognized as a key element in the pathogenesis of diverse diseases. Recent studies have highlighted the intricate links between iron metabolism and neurodegenerative disorders. Emerging evidence suggests that iron homeostasis, oxidative stress, and neuroinflammation all contribute to the regulation of both ferroptosis and neuronal health. However, the precise molecular mechanisms underlying the involvement of ferroptosis in the pathological processes of neurodegeneration and its impact on neuronal dysfunction remain incompletely understood. In our Review, we provide a comprehensive analysis and summary of the potential molecular mechanisms underlying ferroptosis in neurodegenerative diseases, aiming to elucidate the disease progression of neurodegeneration. Additionally, we discuss potential therapeutic agents that modulate ferroptosis with the goal of identifying novel drug molecules for the treatment of neurodegenerative disorders.Keywords
Funding Information
- National Key Research and Development Program of China (2018YFA0108301)
- Science and Technology Commission of Shanghai Municipality (21XD1424900)
- National Natural Science Foundation of China (81673485, 81773719, 81971306, 81973312, 82073915, 82104530)
This publication has 172 references indexed in Scilit:
- Loss of cysteinyl-tRNA synthetase (CARS) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivationCell Death & Differentiation, 2015
- Tau stabilizes microtubules by binding at the interface between tubulin heterodimersProceedings of the National Academy of Sciences, 2015
- Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagyNature, 2014
- Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's diseaseNeurobiology of Aging, 2013
- Human P301L-Mutant Tau Expression in Mouse Entorhinal-Hippocampal Network Causes Tau Aggregation and Presynaptic Pathology but No Cognitive DeficitsPLOS ONE, 2012
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron exportNature Medicine, 2012
- Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophagesArchives of Biochemistry and Biophysics, 2011
- Selective Acetylcholinesterase Inhibitor Activated by Acetylcholinesterase Releases an Active Chelator with Neurorescuing and Anti-Amyloid ActivitiesACS Chemical Neuroscience, 2010
- Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington’s disease gene carriers and healthy subjectsJournal of Neurology, 2007